Key Points Compounded tirzepatide was temporarily allowed during supply shortages as an affordable alternative to brand-name versions FDA officially ended compounded tirzepatide sales after March 19, 2025, with courts upholding the decision in early May 2025 FDA-approved Mounjaro and Zepbound remain the legitimate way to access tirzepatide When tirzepatide came out in 2022, the weight loss results got everyone talking
Upset stomach or other digestive issues might also lead to drinking less water
Plants fail to germinate or grow differentially in response to cold stress
Both Zepbound and Mounjaro contain the same tirzepatide doses, but their FDA-approved uses differ
acpjournals.org/doi/10.7326/AN #MedTwitter #ObesityMedicine #GLP1 #ClinicalResearch GLP-1 therapies lead to weight loss mainly from fat, but a portion includes muscle
For hair regrowth specifically, protocols typically employ subcutaneous administration with careful attention to dosing and timing
